Nasdaq · Common stock
Entera Bio (ENTX)
$2.86 −$0.06 (−2.05%)
- Day’s range
- $2.80–$2.90
- Volume
- 232,460
ENTX price history
ENTX closed at $2.86 on Oct. 26, 2026. Over the past year, its daily close ranged from $1.00 on March 30, 2026 to $3.92 on July 27, 2026.
Data table: ENTX daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $2.86 |
| Oct. 23, 2026 | $2.92 |
| Oct. 22, 2026 | $3.02 |
| Oct. 21, 2026 | $3.05 |
| Oct. 20, 2026 | $3.02 |
| Oct. 19, 2026 | $2.94 |
| Oct. 16, 2026 | $2.68 |
| Oct. 15, 2026 | $2.77 |
| Oct. 14, 2026 | $2.50 |
| Oct. 13, 2026 | $2.49 |
| Oct. 12, 2026 | $2.65 |
| Oct. 9, 2026 | $2.66 |
| Oct. 8, 2026 | $2.50 |
| Oct. 7, 2026 | $2.51 |
| Oct. 6, 2026 | $2.53 |
| Oct. 5, 2026 | $2.62 |
| Oct. 2, 2026 | $2.86 |
| Oct. 1, 2026 | $2.89 |
| Sept. 30, 2026 | $2.91 |
| Sept. 29, 2026 | $2.69 |
| Sept. 28, 2026 | $2.69 |
| Sept. 25, 2026 | $2.75 |
| Sept. 24, 2026 | $2.80 |
| Sept. 23, 2026 | $2.81 |
| Sept. 22, 2026 | $2.98 |
| Sept. 21, 2026 | $2.96 |
| Sept. 18, 2026 | $2.96 |
| Sept. 17, 2026 | $3.03 |
| Sept. 16, 2026 | $2.96 |
| Sept. 15, 2026 | $2.86 |
| Sept. 14, 2026 | $2.82 |
| Sept. 11, 2026 | $2.84 |
| Sept. 10, 2026 | $2.79 |
| Sept. 9, 2026 | $2.84 |
| Sept. 8, 2026 | $3.01 |
| Sept. 4, 2026 | $3.00 |
| Sept. 3, 2026 | $2.95 |
| Sept. 2, 2026 | $2.92 |
| Sept. 1, 2026 | $2.90 |
| Aug. 31, 2026 | $2.95 |
| Aug. 28, 2026 | $3.03 |
| Aug. 27, 2026 | $3.08 |
| Aug. 26, 2026 | $3.19 |
| Aug. 25, 2026 | $3.47 |
| Aug. 24, 2026 | $3.42 |
| Aug. 21, 2026 | $3.23 |
| Aug. 20, 2026 | $3.22 |
| Aug. 19, 2026 | $3.11 |
| Aug. 18, 2026 | $2.89 |
| Aug. 17, 2026 | $2.90 |
| Aug. 14, 2026 | $2.89 |
| Aug. 13, 2026 | $2.87 |
| Aug. 12, 2026 | $2.80 |
| Aug. 11, 2026 | $3.00 |
| Aug. 10, 2026 | $3.04 |
| Aug. 7, 2026 | $2.87 |
| Aug. 6, 2026 | $2.82 |
| Aug. 5, 2026 | $2.81 |
| Aug. 4, 2026 | $2.87 |
| Aug. 3, 2026 | $2.96 |
| July 31, 2026 | $2.99 |
| July 30, 2026 | $2.95 |
| July 29, 2026 | $3.00 |
| July 28, 2026 | $3.26 |
| July 27, 2026 | $3.92 |
| July 24, 2026 | $2.05 |
| July 23, 2026 | $2.13 |
| July 22, 2026 | $2.03 |
| July 21, 2026 | $1.96 |
| July 20, 2026 | $1.99 |
| July 17, 2026 | $1.98 |
| July 16, 2026 | $2.00 |
| July 15, 2026 | $1.78 |
| July 14, 2026 | $1.62 |
| July 13, 2026 | $1.64 |
| July 10, 2026 | $1.66 |
| July 9, 2026 | $1.70 |
| July 8, 2026 | $1.69 |
| July 7, 2026 | $1.66 |
| July 6, 2026 | $1.71 |
| July 2, 2026 | $1.66 |
| July 1, 2026 | $1.69 |
| June 30, 2026 | $1.77 |
| June 29, 2026 | $1.65 |
| June 26, 2026 | $1.63 |
| June 25, 2026 | $1.45 |
| June 24, 2026 | $1.54 |
| June 23, 2026 | $1.55 |
| June 22, 2026 | $1.48 |
| June 18, 2026 | $1.21 |
| June 17, 2026 | $1.20 |
| June 16, 2026 | $1.18 |
| June 15, 2026 | $1.21 |
| June 12, 2026 | $1.23 |
| June 11, 2026 | $1.16 |
| June 10, 2026 | $1.17 |
| June 9, 2026 | $1.22 |
| June 8, 2026 | $1.20 |
| June 5, 2026 | $1.18 |
| June 4, 2026 | $1.22 |
| June 3, 2026 | $1.22 |
| June 2, 2026 | $1.25 |
| June 1, 2026 | $1.27 |
| May 29, 2026 | $1.35 |
| May 28, 2026 | $1.22 |
| May 27, 2026 | $1.19 |
| May 26, 2026 | $1.21 |
| May 22, 2026 | $1.24 |
| May 21, 2026 | $1.27 |
| May 20, 2026 | $1.24 |
| May 19, 2026 | $1.27 |
| May 18, 2026 | $1.23 |
| May 15, 2026 | $1.26 |
| May 14, 2026 | $1.32 |
| May 13, 2026 | $1.29 |
| May 12, 2026 | $1.25 |
| May 11, 2026 | $1.17 |
| May 8, 2026 | $1.30 |
| May 7, 2026 | $1.37 |
| May 6, 2026 | $1.25 |
| May 5, 2026 | $1.16 |
| May 4, 2026 | $1.11 |
| May 1, 2026 | $1.10 |
| April 30, 2026 | $1.19 |
| April 29, 2026 | $1.12 |
| April 28, 2026 | $1.13 |
| April 27, 2026 | $1.15 |
| April 24, 2026 | $1.12 |
| April 23, 2026 | $1.17 |
| April 22, 2026 | $1.22 |
| April 21, 2026 | $1.19 |
| April 20, 2026 | $1.34 |
| April 17, 2026 | $1.28 |
| April 16, 2026 | $1.20 |
| April 15, 2026 | $1.18 |
| April 14, 2026 | $1.13 |
| April 13, 2026 | $1.12 |
| April 10, 2026 | $1.15 |
| April 9, 2026 | $1.15 |
| April 8, 2026 | $1.17 |
| April 7, 2026 | $1.17 |
| April 6, 2026 | $1.19 |
| April 2, 2026 | $1.26 |
| April 1, 2026 | $1.14 |
| March 31, 2026 | $1.11 |
| March 30, 2026 | $1.00 |
| March 27, 2026 | $1.13 |
| March 26, 2026 | $1.03 |
| March 25, 2026 | $1.18 |
| March 24, 2026 | $1.03 |
| March 23, 2026 | $1.09 |
| March 20, 2026 | $1.11 |
| March 19, 2026 | $1.19 |
| March 18, 2026 | $1.34 |
| March 17, 2026 | $1.38 |
| March 16, 2026 | $1.35 |
| March 13, 2026 | $1.27 |
| March 12, 2026 | $1.32 |
| March 11, 2026 | $1.39 |
| March 10, 2026 | $1.49 |
| March 9, 2026 | $1.33 |
| March 6, 2026 | $1.25 |
| March 5, 2026 | $1.23 |
| March 4, 2026 | $1.30 |
| March 3, 2026 | $1.34 |
| March 2, 2026 | $1.37 |
| Feb. 27, 2026 | $1.39 |
| Feb. 26, 2026 | $1.51 |
| Feb. 25, 2026 | $1.58 |
| Feb. 24, 2026 | $1.58 |
| Feb. 23, 2026 | $1.58 |
| Feb. 20, 2026 | $1.47 |
| Feb. 19, 2026 | $1.42 |
| Feb. 18, 2026 | $1.40 |
| Feb. 17, 2026 | $1.42 |
| Feb. 13, 2026 | $1.50 |
| Feb. 12, 2026 | $1.52 |
| Feb. 11, 2026 | $1.64 |
| Feb. 10, 2026 | $1.45 |
| Feb. 9, 2026 | $1.33 |
| Feb. 6, 2026 | $1.04 |
| Feb. 5, 2026 | $1.17 |
| Feb. 4, 2026 | $1.20 |
| Feb. 3, 2026 | $1.23 |
| Feb. 2, 2026 | $1.33 |
| Jan. 30, 2026 | $1.37 |
| Jan. 29, 2026 | $1.46 |
| Jan. 28, 2026 | $1.47 |
| Jan. 27, 2026 | $1.55 |
| Jan. 26, 2026 | $1.53 |
| Jan. 23, 2026 | $1.60 |
| Jan. 22, 2026 | $1.58 |
| Jan. 21, 2026 | $1.58 |
| Jan. 20, 2026 | $1.57 |
| Jan. 16, 2026 | $1.62 |
| Jan. 15, 2026 | $1.58 |
| Jan. 14, 2026 | $1.63 |
| Jan. 13, 2026 | $1.46 |
| Jan. 12, 2026 | $1.57 |
| Jan. 9, 2026 | $1.60 |
| Jan. 8, 2026 | $1.74 |
| Jan. 7, 2026 | $1.59 |
| Jan. 6, 2026 | $1.57 |
| Jan. 5, 2026 | $1.77 |
| Jan. 2, 2026 | $1.77 |
| Dec. 31, 2025 | $1.94 |
| Dec. 30, 2025 | $2.00 |
| Dec. 29, 2025 | $1.80 |
| Dec. 26, 2025 | $1.72 |
| Dec. 24, 2025 | $1.74 |
| Dec. 23, 2025 | $1.76 |
| Dec. 22, 2025 | $1.88 |
| Dec. 19, 2025 | $1.77 |
| Dec. 18, 2025 | $1.94 |
| Dec. 17, 2025 | $1.97 |
| Dec. 16, 2025 | $2.09 |
| Dec. 15, 2025 | $2.08 |
| Dec. 12, 2025 | $2.16 |
| Dec. 11, 2025 | $2.21 |
| Dec. 10, 2025 | $2.12 |
| Dec. 9, 2025 | $2.07 |
| Dec. 8, 2025 | $2.13 |
| Dec. 5, 2025 | $2.15 |
| Dec. 4, 2025 | $2.11 |
| Dec. 3, 2025 | $2.06 |
| Dec. 2, 2025 | $2.22 |
| Dec. 1, 2025 | $2.29 |
| Nov. 28, 2025 | $2.38 |
| Nov. 26, 2025 | $2.38 |
| Nov. 25, 2025 | $2.49 |
| Nov. 24, 2025 | $2.38 |
| Nov. 21, 2025 | $2.53 |
| Nov. 20, 2025 | $2.58 |
| Nov. 19, 2025 | $2.65 |
| Nov. 18, 2025 | $2.60 |
| Nov. 17, 2025 | $2.68 |
| Nov. 14, 2025 | $2.71 |
| Nov. 13, 2025 | $2.74 |
| Nov. 12, 2025 | $2.91 |
| Nov. 11, 2025 | $3.01 |
| Nov. 10, 2025 | $3.00 |
| Nov. 7, 2025 | $3.14 |
| Nov. 6, 2025 | $3.11 |
| Nov. 5, 2025 | $3.04 |
| Nov. 4, 2025 | $2.80 |
| Nov. 3, 2025 | $2.84 |
| Oct. 31, 2025 | $2.91 |
| Oct. 30, 2025 | $2.82 |
| Oct. 29, 2025 | $2.73 |
| Oct. 28, 2025 | $2.52 |
| Oct. 27, 2025 | $2.33 |
Key figures
- 52-week range
- $1.00–$3.92Low March 30, 2026; high July 27, 2026
- Average daily volume
- 551,807Past 3 months
- Market value
- $497.4M
- Dividend yield
- —
- From 52-week high
- −27.04%
Price change
- 1 month
- +4.19%
- 3 months
- +39.51%
- Year to date
- +47.42%
- 1 year
- +28.83%
$1,000 a year ago
$1,000 put into ENTX at the close on Oct. 24, 2025 would be worth $1,288.
Price only, dividends not included.
What Wall Street says about ENTX
In the past 90 days, Wall Street firms published 4 rating or price-target actions on ENTX: 4 new ratings.
| Action | Rating | |||
|---|---|---|---|---|
| Guggenheim | Initiates coverage | Buy | $11 | |
| LifeSci Capital | Initiates coverage | Outperform | $10 | |
| Cantor Fitzgerald | Initiates coverage | Overweight | — | |
| Leerink Partners | Initiates coverage | Outperform | $9 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Entera Bio Ltd. Ordinary Shares
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
- Headquarters
- Jerusalem
- Employees
- 22
- Listed
- June 28, 2018
- Sector
- Health care
- Industry
- Biological products, (no diagnostic substances)
In WallStreetDigest editions
No WallStreetDigest article about ENTX is on the site yet.